Assessment of Quality of Life After Acute Mesenteric Ischemia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France

About this trial

Acute mesenteric ischemia is a severe abdominal emergency associated with a poor prognosis. While numerous studies have been conducted on the incidence, outcomes, and risk factors of mesenteric ischemia, very few focus on the quality of life of patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patient (≥ 18 years)

Treated for mesenteric ischemia between 2010 and 2022 in the intensive care, cardiovascular, and digestive and vascular surgery departments of the Strasbourg University Hospitals

Disqualifiers

Chronic mesenteric ischemia or other non-ischemic intestinal vascular pathologies such as mechanical causes.

Colonic ischemia

Trial population

Adult patient (≥ 18 years) treated for mesenteric ischemia in the Strasbourg University Hospitals

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Score of GIQLI (Gastrointestinal Quality of Life Index)

The GIQLI quality of life score consists of 36 items: the higher the score, the better the quality of life.

Time frame
Up to 12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.